Vance Lemmon

Co-Founder
Truvitech
Vance Lemmon

Dr. Lemmon’s research activities focus on the use of phenotypic screening to identify gene targets and compounds that can be developed into therapeutics for nervous system repair. He is an internationally recognized expert in high throughput microscopy and analytical approaches to explore enormous image-based data sets. Dr. Lemmon has extensive experience in assay development, and has used ontologies, semantic reasoning, and artificial intelligence to identify novel targets for neural regeneration

Manténgase Informado